Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride

Skoug, 1989, Qualitative evaluation of mechanism of release of matrix sustained release dosage forms by measurements of polymer release, J. Control. Release, 27, 227, 10.1016/0168-3659(93)90154-W

Ranga Rao, 1989, Swelling controlled release systems: recent developments and applications, Int. J. Pharm., 48, 1, 10.1016/0378-5173(88)90245-1

Sánchez-Lafuente, 2002, Development of sustained release matrix tablets of didanosine containing methacrylic and ethylcellulose polymers, Int. J. Pharm., 234, 213, 10.1016/S0378-5173(01)00962-0

Khan, 1998, Formulation and in-vitro evaluation of ibuprofen-carbopol 974P-NF controlled release matrix tablets: III. Influence of co-excipients on release rate of drug, J. Control. Release, 54, 185, 10.1016/S0168-3659(97)00225-3

Boniferoni, 1995, Influence of medium on dissolution–erosion behavior of Na-carboxymethylcellulose and on viscoelastic properties of gels, Int. J. Pharm., 117, 41, 10.1016/0378-5173(94)00310-2

Ranga Rao, 1990, Influence of molecular size and water solubility of the solutes on its release from swelling and erosion controlled polymeric matrices, J. Control. Release, 12, 133, 10.1016/0168-3659(90)90089-C

Mannion, 1991, Effect of xanthane/locust bean gum synergyon on ibuprofen release from hydrophilic matrix tablets, J. Pharm. Pharmacol., 43, 78

Billa, 2000, Gamma-scintigraphic study of the gastrointestinal transit and in-vivo dissolution of controlled release diclofenac sodium formulations in xanthane gum matrices, Int. J. Pharm., 201, 109, 10.1016/S0378-5173(00)00399-9

Toti, 2002, New controlled release diltiazem hydrochloride tablets: in-vitro release study, 197

Raid, 1985, 265

McCleary, 1981, The fine structure of carob and guar galactomannans, Carbohydr. Res., 92, 269, 10.1016/S0008-6215(00)80398-5

Baveja, 1991, Chemical investigation of galactomannan gums as matrix tablets for sustained drug delivery, Indian J. Chem., 30, 133

Skinner, 1998, Evaluation of water soluble polymers in phenylpropanolamine sustained release tablet, S14

Khullar, 1998, Guar gum as a hydrophilic matrix for preparation of theophylline controlled release dosage form, Drug Dev. Ind. Pharm., 24, 1095, 10.3109/03639049809089955

Altaf, 1998, Guar gum based sustained release diltiazem, Pharm. Res., 15, 1196, 10.1023/A:1011931622536

Krishnaiah, 2001, A study on the in-vitro evaluation of guar gum as a carrier for oral contolled drug delivery, Saudi Pharm. J., 9, 91

Jain, 1992, Controlled-release tablet formulation of Isoniazid, Pharmazine, 47, 277

Krishnaiah, 2002, Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazine dihydrochloride, J. Control. Release, 81, 45, 10.1016/S0168-3659(02)00031-7

Rama Prasad, 1998, In vitro evaluation of guar gum as a carrier for colon-specific drug delivery, J. Control. Release, 51, 281, 10.1016/S0168-3659(97)00181-8

Krishnaiah, 1999, Studies on guar gum compression coated 5-amino salicylic acid tablets for colon-specific drug delivery, Drug Dev. Ind. Pharm., 25, 651, 10.1081/DDC-100102221

Gliko-Kabir, 2000, Phosphated cross-linked guar for colon-specific drug delivery: I. Preparation and physicochemical characterization, J. Control. Release, 63, 121, 10.1016/S0168-3659(99)00179-0

Toti, 2002, Sorption, diffusion and pervaporation separation of water–acetic acid mixtures through the blend membranes of sodium alginate and guar gum grafted polyacrylamide, J. Appl. Polym. Sci., 83, 259, 10.1002/app.2241

Soppimath, 2002, Water transport and drug release study from cross-linked poly acrylamide grafted guar gum hydrogel microspheres for the controlled release application, Eur. J. Pharm. Biopharm., 53, 87, 10.1016/S0939-6411(01)00205-3

Soppimath, 2001, Chemically modified polyacrylamide-g-guar gum based cross-linked anionic microgels as pH-sensitive drug delivery systems: preparation and characterization, J. Control. Release, 75, 331, 10.1016/S0168-3659(01)00404-7

Feely, 1988, The influence of polymeric excipients on drug release from hydroxy propyl methyl cellulose matrices, Int. J. Pharm., 44, 131, 10.1016/0378-5173(88)90109-3

Brossard, 1990, Contrôle de dissolution des formes pharmaceutiques orales solides à liberation ralentie, STP Pharma, 6, 728

Ratsimbazafy, 1999, Rheological behavior of drug suspensions in Gelucire mixtures and proxyphylline release from matrix hard gelatin capsules, Eur. J. Pharm. Biopharm., 48, 247, 10.1016/S0939-6411(99)00042-9

Higuchi, 1963, Mechanism of sustained action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci., 52, 1145, 10.1002/jps.2600521210

Kopcha, 1991, Evaluation of release from selected thermosoftening vehicles, J. Pharm. Pharmacol., 43, 382, 10.1111/j.2042-7158.1991.tb03493.x

Ratsimbazafy, 1996, Drug release from matrix tablets and minitablets containing glycerides, Pharm. Ind., 58, 442